[1] Miyauchi A, Ito Y. Conservative Surveillance management of low-risk papillary thyroid microcarcinoma[J]. Endocrinol Metab Clin North Am, 2019,48(1):215-226.
[2] Olson E, Wintheiser G, Wolfe K M, et al. Epidemiology of thyroid cancer: a review of the national cancer database, 2000-2013[J]. Cureus, 2019, 11(2): e4127.
[3] Yoshida Y, Horiuchi K, Okamoto T. Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery [J]. Thyroid, 2020,30(5):681-687.
[4] Haugen B R, Alexander E K, Bible K C, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
[5] Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study[J]. Thyroid, 2016, 26(11):1581-1587.
[6] Xu E J, Lv S M, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging[J]. Int J Hyperthermia, 2018, 34(6):870-876.
[7] Vogl T J, Nour-Eldin N A, Albrecht M H, et al. Thermal ablation of lung tumors: focus on microwave ablation [J]. Rofo, 2017, 189(9): 828-843.
[8] Bale R, Putzer D, Schullian P. Local treatment of breast cancer liver metastasis [J]. Cancers (basel), 2019, 11(9):1341.
[9] Baek J H, Lee J H, Valcavi R, et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser [J]. Korean J Radiol, 2011, 12(5): 525-540.
[10] Sartori S, Mauri G, Tombesi P, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk [J]. Int J Hyperthermia, 2018, 35(1):19-25.
[11] 中国医师协会超声医师分会. 甲状腺微小乳头状癌热消融诊疗指征专家共识[J]. 中华医学超声杂志(电子版), 2019, 16(8): 571-574.
[12] 田 文, 王 宇, 郗洪庆, 等. 甲状腺疾病射频消融治疗现状与争议[J]. 中国实用外科杂志, 2018, 38(1): 75-78.
[13] Cho S J, Baek S M, Lim H K, et al. Long-term follow-up rResults of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors[J]. Thyroid, 2020, 30(12):1745-1751.
[14] Zhang M, Tufano R P, Russell J O, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years' follow-up[J]. Thyroid, 2020, 30(3): 408-417.
[15] 盛欢欢, 苏丽娟, 李 莹. 超声引导下RFA治疗甲状腺微小乳头状癌的效果[J]. 中国现代普通外科进展, 2020, 23(4): 306-307.
[16] 沈 吉, 徐华军, 熊伟律. 超声引导射频与微波消融治疗甲状腺微小乳头状癌的效果对比[J]. 中国医药导报, 2019, 16(7):131-135, 182.
[17] Vorlnder C, David Kohlhase K, Korkusuz Y, et al. Comparison between microwave ablation and bipolar radiofrequency ablation in benign thyroid nodules: differences in energy transmission, duration of application and applied shots [J]. Int J Hyperthermia, 2018, 35(1): 216-225.
[18] Teng D K, Li W H, Du J R, et al. Effects of microwave ablation on papillary thyroid microcarcinoma: a five-year follow-up report [J]. Thyroid, 2020, 30(12): 1752-1758.
[19] Yue W W, Qi L, Wang D D, et al. US-guided microwave ablation of low-risk papillary thyroid microcarcinoma: longer-term results of a prospective study [J]. J Clin Endocrinol Metab, 2020, 105(6): 1791-1800.
[20] Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk [J]. Thyroid, 2011, 21(8):917-920.
[21] 季莉丽, 顾 军, 周 峰, 等. 超声引导激光消融治疗甲状腺微小乳头状癌与外科手术切除的对比研究[J]. 南通大学学报(医学版),2019,39(4): 256-260.
[22] 喻可知, 周 平, 刘稳刚, 等. 超声引导经皮激光消融治疗单发甲状腺微小乳头状癌的疗效研究[J]. 中国超声医学杂志, 2019, 35(4): 292-295.
[23] Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response [J]. World J Surg, 2018, 42(8): 2476-2484.
[24] 章建全, 盛建国, 刁宗平, 等. 液体隔离法在颈部结节性病变经皮热消融治疗中的应用[J]. 第二军医大学学报, 2014, 35(10):1045-1052.
[25] 杨映弘, 颜 璟, 吴艳军, 等. 液体隔离带法与杠杆撬离法在超声引导下甲状腺微波消融术中的应用比较 [J]. 中国现代普通外科进展, 2018, 21(1): 28-30.
[26] 颜燕煌, 林 晶, 高子斌, 等. 甲状腺微小乳头状癌144例热消融范围探讨[J]. 肿瘤学杂志, 2019, 25(10): 924-925.
[27] Bo X W, Lu F, Xu H X, et al. Thermal ablation of benign thyroid nodules and papillary thyroid microcarcinoma [J]. Front Oncol, 2020, 10: 580431.
[28] 何 杰, 李新营, 王志明, 等. 多灶性甲状腺微小乳头状癌临床病理特征及预防性中央区淋巴结清扫的意义[J]. 中国普通外科杂志, 2017, 26(11):1405-1410.
[29] 卫旭东. 《甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)》解读[J]. 中国眼耳鼻喉科杂志, 2019, 19(6):431-434.
[30] 王中琴. 超声引导下经皮微波消融与外科手术切除治疗甲状腺微小乳头状癌的临床效果与安全性分析[J]. 医学理论与实践, 2020, 33(11):1788-1790.
[31] Kim T Y, Hong S J, Kim J M, et al. Prognostic parameters for recurrence of papillary thyroid microcarcinoma [J]. BMC Cancer, 2008, 8: 296.
[32] Wu X, Li B, Zheng C, et al. Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma[J]. Medicine (Baltimore), 2019,98(27): e16386.
[33] Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J]. Thyroid, 2014, 24(1): 27-34.
[34] Chu K F, Dupuy D E. Thermal ablation of tumours: biological mechanisms and advances in therapy[J]. Nat Rev Cancer, 2014, 14(3): 199-208.
[35] Vanagas T, Gulbinas A, Pundzius J, et al. Radiofrequency ablation of liver tumors (I): biological background [J]. Medicina (Kaunas), 2010, 46(1):13-17.
[36] Singh S, Melnik R. Thermal ablation of biological tissues in disease treatment: a review of computational models and future directions[J]. Electromagn Biol Med, 2020, 39(2):49-88.
[37] Choi Y, Jung S L. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis[J]. Thyroid, 2020, 30(5):720-731.